TopFunds

Merck & Co., Inc.

NYSE: MRK

Stock price

146.76 USD

(+104.74%) 5 years

Drug Manufacturers - General

Insider Transactions

5Y price score: 144
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +104.74%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
13-aug.-26Sale(10,000)135.0(1,350,000)36,613Guindo Chirfiofficer: EVP, Access, Policy & Commslink
12-aug.-26Sale(80,315)133.5(10,718,495)45,509Zachary Jenniferofficer: EVP, General Counsellink
12-aug.-26Sale(11,099)131.6(1,460,770)110,767DeLuca Richard R.officer: EVP&Pres, Merck Animal Heallthlink
12-aug.-26Sale(600)132.0(79,222)110,167DeLuca Richard R.officer: EVP&Pres, Merck Animal Heallthlink
11-aug.-26Sale(7,410)131.3(973,165)127,293DeLuca Richard R.officer: EVP&Pres, Merck Animal Heallthlink
11-aug.-26Sale(5,427)132.3(718,261)121,866DeLuca Richard R.officer: EVP&Pres, Merck Animal Heallthlink
10-aug.-26Sale(20,784)130.4(2,710,951)134,703DeLuca Richard R.officer: EVP&Pres, Merck Animal Heallthlink
06-aug.-26Sale(805)131.0(105,472)160,732DeLuca Richard R.officer: EVP&Pres, Merck Animal Heallthlink
06-aug.-26Sale(4,945)130.2(643,993)155,787DeLuca Richard R.officer: EVP&Pres, Merck Animal Heallthlink
06-aug.-26Sale(300)131.0(39,307)155,487DeLuca Richard R.officer: EVP&Pres, Merck Animal Heallthlink

77.5

52-week range

156.9

146.76

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

4.4 %

Dividend Yield TTM

2.3 %

Market cap $

$ 362,471

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

117.4

Price / Book TTM

8.7

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

14.7

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

84 %

125.3 %

188.8 %

Free cash flow per share growth

80 %

115.1 %

25.8 %

Earnings per share growth

(130.7) %

161.9 %

366.7 %

Dividends

Previous dividend:0.85 per share, Paid, Ex-div date Jun 15, 2026
Next dividend:0.85 per share, Declared, Ex-div date Sep 15, 2026

Analyst ratings

Price Target Low

105

Price Target High

180

Price Target Median

161

Buy

26

Hold

11

Sell

1

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
1.6
2
0.9
2.3
3.8
2.8
5.1
5.7
0.1
6.7
7.3
16.7%
4.8
5.1
5.4
5.8
6.1
6.4
02FCF per share
3.9
3.1
1.7
3.1
3.9
2.3
3.8
5.8
3.6
7.1
4.9
2.3%
5.7
5.9
6.1
6.3
6.5
6.5
03Dividends per share
Help
Adjusted for splitsLearn more
1.7
1.8
1.8
1.9
2.2
2.4
2.6
2.8
3
3.1
3.3
6.6%
-
-
-
-
-
-
04Dividends payout, %
115.2%
130.7%
215.8%
83.2%
57.9%
87.9%
50.7%
48.3%
2,039.7%
45.8%
44.8%
(9)%
-
-
-
-
-
-
05Revenue
$ 39,498
$ 39,807
$ 40,122
$ 42,294
$ 39,121
$ 41,518
$ 48,704
$ 59,283
$ 60,115
$ 64,168
$ 64,926
5.1%
$ 68,234
$ 71,711
$ 75,365
$ 79,206
$ 83,242
$ 85,739
06ㅤ% Change
-
0.8%
0.8%
5.4%
(7.5)%
6.1%
17.3%
21.7%
1.4%
6.7%
1.2%
5.1%
5.1%
5.1%
5.1%
5.1%
5.1%
5.1%
07Net Income
4,442
3,920
2,394
6,220
9,843
7,067
13,049
14,519
365
17,117
18,254
15.2%
11,825
12,428
13,061
13,726
14,426
14,859
08ㅤ% Margin
11.3%
9.9%
6%
14.7%
25.2%
17%
26.8%
24.5%
0.6%
26.7%
28.1%
17.3% A
17.3%
17.3%
17.3%
17.3%
17.3%
17.3%
09CFO
12,421
10,376
6,447
10,922
13,440
10,253
14,109
19,095
13,006
21,468
16,472
2.9%
18,615
19,564
20,561
21,608
22,710
23,391
10ㅤ% Of revenue
31.5%
26.1%
16.1%
25.8%
34.4%
24.7%
29%
32.2%
21.6%
33.5%
25.4%
27.3% A
27.3%
27.3%
27.3%
27.3%
27.3%
27.3%
11CAPEX
(1,283)
(1,614)
(1,888)
(2,615)
(3,473)
(4,429)
(4,448)
(4,388)
(3,863)
(3,372)
(4,112)
12.4%
(4,620)
(5,191)
(5,832)
(6,552)
(7,362)
(8,271)
12ㅤ% Change
-
25.8%
17%
38.5%
32.8%
27.5%
0.4%
(1.4)%
(12)%
(12.7)%
22%
12.4% A
12.4%
12.4%
12.4%
12.4%
12.4%
12.4%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
11,138
8,762
4,559
8,307
9,967
5,824
9,661
14,707
9,143
18,096
12,360
1.1%
13,995
14,373
14,729
15,056
15,348
15,120
14Total assets
101,677
95,377
87,872
82,637
84,397
91,588
105,694
109,160
106,675
117,106
136,866
3%
140,995
145,248
149,630
154,143
158,793
163,583
15ㅤ% Change
-
(6.2)%
(7.9)%
(6)%
2.1%
8.5%
15.4%
3.3%
(2.3)%
9.8%
16.9%
3%
3%
3%
3%
3%
3%
3%
16Total liabilities
56,910
55,069
53,303
55,755
58,396
66,184
67,437
63,102
69,040
70,734
84,204
4%
86,744
89,361
92,057
94,834
97,694
100,641
17ㅤ% Of assets
56%
57.7%
60.7%
67.5%
69.2%
72.3%
63.8%
57.8%
64.7%
60.4%
61.5%
61.5% A
61.5%
61.5%
61.5%
61.5%
61.5%
61.5%
18Shareholders Equity
44,767
40,308
34,569
26,882
26,001
25,404
38,257
46,058
37,635
46,372
52,662
1.6%
54,251
55,887
57,573
59,310
61,099
62,942
19Net Debt
17,888
18,327
18,318
17,149
17,675
25,367
26,535
19,291
29,427
25,028
35,969
7.2%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
2,841,000
2,787,000
2,748,000
2,679,000
2,580,000
2,541,000
2,538,000
2,542,000
2,547,000
2,541,000
2,507,000
(1.2)%
2,475,840
2,445,068
2,414,678
2,384,666
2,355,027
2,325,756
21ㅤ% Change
-
(1.9)%
(1.4)%
(2.5)%
(3.7)%
(1.5)%
(0.1)%
0.2%
0.2%
(0.2)%
(1.3)%
(1.2)%
(1.2)%
(1.2)%
(1.2)%
(1.2)%
(1.2)%
(1.2)%
22ROA
4.4%
4.1%
2.7%
7.5%
11.7%
7.7%
12.4%
13.3%
0.3%
14.6%
13.3%
-
8.4%
8.6%
8.7%
8.9%
9.1%
9.1%
23ROE
9.9%
9.7%
6.9%
23.1%
37.9%
27.8%
34.1%
31.5%
1%
36.9%
34.7%
-
21.8%
22.2%
22.7%
23.1%
23.6%
23.6%
24Interest coverage
11.2
7.9
9
11.6
8.9
6.7
16.4
19
2.6
15.9
17.3
-
-
-
-
-
-
-
25Dividend Yield
3.7%
3.3%
3.6%
2.7%
2.6%
3.2%
3.4%
2.5%
2.7%
3.1%
3.1%
-
-
-
-
-
-
-
26P/E Ratio
31.5
27.1
56.5
30.4
22.6
28
14.9
19.4
778.7
14.7
14.4
-
-
-
-
-
-
-
27Stock price range
46-60
46-62
52-63
51-76
70-87
63-88
69-91
74-112
100-118
96-133
73-107
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
140,085
154,286
144,673
188,894
222,437
197,340
193,899
280,925
284,231
251,883
263,931
6.5%
153,687
172,647
193,503
216,445
241,681
-
29FCF Yield
8%
5.7%
3.2%
4.4%
4.5%
3%
5%
5.2%
3.3%
7.2%
4.7%
(5.2)%
9.1%
8.3%
7.6%
7%
6.4%
-
30Average stock price
53.1
54.1
57.5
63.2
78.5
75.5
79.7
92.8
109.3
114.6
90.1
5.4%
62.1
70.6
80.1
90.8
102.6
-
31 CEO
RD
Robert Davis